TRV-2026-0047Version 2 · Retracted
Reason for this version
Model backfill: source did not support a publishable AI-impact claim
Canonical text (the exact bytes fingerprinted)
TRUVACE RECORD VERSION record: TRV-2026-0047 version: 2 kind: retracted reason: Model backfill: source did not support a publishable AI-impact claim timestamp: 2026-07-13T00:40:03.935934Z status: archived lens: p_space sector: health headline: Evolut r transcatheter aortic valve: FDA injury report involving AI dek: The FDA received a injury report involving Evolut r transcatheter aortic valve, made by Medtronic mexico s. de r.l. de cv. It was reported that 7 months following the implant of a transcatheter aortic valve, leaflet thickening was identified via computed tomography angiogram (cta) that was further analyzed via a non-medtronic artificial intelligence (ai)-powered simulation. the patient is being evaluated for a transcatheter valve-in-valve procedure. gain_title: (none) problem_title: An FDA adverse-event report linked Evolut r transcatheter aortic valve to an AI-related injury; the report requires investigation and does not by itself establish causality. trace_subject: (none) gain_reading: (none) problem_reading: An FDA adverse-event report linked Evolut r transcatheter aortic valve to an AI-related injury; the report requires investigation and does not by itself establish causality. quick_read: The FDA received a injury report involving Evolut r transcatheter aortic valve, made by Medtronic mexico s. de r.l. de cv. It was reported that 7 months following the implant of a transcatheter aortic valve, leaflet thickening was identified via computed tomography angiogram (cta) that was further analyzed via a non-medtronic artificial intelligence (ai)-powered simulation. the patient is being evaluated for a transcatheter valve-in-valve procedure. limitation: FDA adverse-event reports can be incomplete, duplicated, or unverified and do not establish that a device caused the reported outcome. tag: Evidence-backed problem key_points: Device: Evolut r transcatheter aortic valve; manufacturer: Medtronic mexico s. de r.l. de cv. | FDA report type: Injury. | An adverse-event report is a safety signal, not proof that the device caused the event. rundown: It was reported that 7 months following the implant of a transcatheter aortic valve, leaflet thickening was identified via computed tomography angiogram (cta) that was further analyzed via a non-medtronic artificial intelligence (ai)-powered simulation. the patient is being evaluated for a transcatheter valve-in-valve procedure. The report is part of FDA’s MAUDE surveillance data. It should be read as a signal for follow-up, not a clinical conclusion or a verified incidence rate. sources: - government | FDA MAUDE report 24706346 | https://api.fda.gov/device/event.json?search=mdr_report_key%3A%2224706346%22&sort=date_received%3Adesc&limit=1 | 2026-03-26 prev: 85ef2873895dc0fd8935816a596bb55305af1aaed6b77e81db7c4726f5ef2660
- sha256
- 57677deb2aecc26d18f84248a162c8feb5c9c64cbe2bef0bc95c09699ef57073
- previous
- 85ef2873895dc0fd8935816a596bb55305af1aaed6b77e81db7c4726f5ef2660
Verify this record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-0047 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.